Aktis Oncology is undervalued, trading below IPO price despite robust cash reserves and two independent clinical programs. AKTS has a cash runway into 2029, supported by $517.3M in cash and a $1.2B+ partnership with Eli Lilly, minimizing near-term dilution risk. AKY-1189 and AKY-2519 offer differentiated radiopharma approaches, with Fast Track status and early human dosimetry data de-risking development.
Aktis Oncology, Inc. (AKTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
A pullback in the AI trade has created opportunities for bargain-hunting investors, according to analysts at Bank of America.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Curtis Ellergodt Rothschild Investment LLC | 39 | $1,257 | $613.47 | -$643.53 | -51.2% |
| NA Nizar Araji National Bank Of Canada /FI/ | 700 | $22,561 | $11,067 | -$11,494 | -50.95% |
George Soros Soros Fund Management LLC | 100,000 | $1.79M | $1.62M | -$165,850 | -9.27% |
John H. Burbank III Passport Capital LLC | 996,351 | $17.82M | $15.8M | -$2.02M | -11.35% |
| MM Mike Muhizi SG Americas Securities LLC | 3,368 | $109,000 | $52,978.64 | -$56,021.36 | -51.4% |
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JJ Jeff Jones Oppenheimer | 2,483.02 | $59,741.36 | $39,057.84 | -$20,683.52 | -34.62% |
| Communications Equipment Industry | Information Technology Sector | Matthew Roden CEO | NASDAQ (CM) Exchange | 01021M104 CUSIP |
| US Country | 79 Employees | - Last Dividend | 24 Apr 2015 Last Split | 14 Mar 2017 IPO Date |
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells innovative radio frequency (RF) filter products for the global mobile wireless device industry. The company operates primarily through two business segments: Foundry Fabrication Services and RF Filters. With facilities located in the United States, Asia, and Europe, Akoustis Technologies serves a worldwide customer base. Founded in 2013, the company's headquarters is in Huntersville, North Carolina. It is dedicated to providing state-of-the-art RF solutions for mobile devices, cellular infrastructure, Wi-Fi customer premise equipment, as well as military and defense applications.
This segment offers specialized engineering review services and backend packaging solutions to clients. It is geared towards companies looking for custom fabrication services in the RF domain, leveraging Akoustis Technologies' expertise and facilities to meet specific design and manufacturing needs.
Under this segment, Akoustis Technologies manufactures and sells a wide range of RF filter products. These products are essential components in various applications, including: